» Articles » PMID: 14527772

In Vitro Activity of Fosfomycin Against Gram-negative Urinary Pathogens and the Biological Cost of Fosfomycin Resistance

Overview
Date 2003 Oct 7
PMID 14527772
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to reassess the activity of fosfomycin against recently isolated uropathogens circulating in Italy and to evaluate the effect of fosfomycin resistance on the expression of several virulence traits using the rare mutant strains. In vitro activity of fosfomycin was evaluated using 441 Gram-negative organisms isolated from patients with uncomplicated urinary tract infections (UTIs). Fosfomycin was the most active antibiotic against Escherichia coli (99% susceptibility). The activity against Proteus mirabilis was more potent than that of co-trimoxazole and nitrofurantoin (87.5, 67 and 0% susceptibility, respectively). The other microorganisms, accounting for about 7% of all pathogens tested, showed variable susceptibilities to fosfomycin. Compared with susceptible strains, fosfomycin-resistant mutants showed a reduced rate of growth and were impaired in their ability to adhere to uroepithelial cells and to urinary catheters. They were also more resistant to UV irradiation and to phage T7 and showed diminished rates of colicin synthesis and transfer of plasmids.

Citing Articles

In Vitro Antibacterial Activities of Fosfomycin against Isolates from Canine Urinary Tract Infection.

Jariyapamornkoon N, Nuanualsuwan S, Suanpairintr N Animals (Basel). 2024; 14(13).

PMID: 38998027 PMC: 11240368. DOI: 10.3390/ani14131916.


Impact of a Primary Care Antimicrobial Stewardship Program on Bacterial Resistance Control and Ecological Imprint in Urinary Tract Infections.

Jover-Saenz A, Ramirez-Hidalgo M, Belles Belles A, Murillo E, Batlle Bosch M, Cayado Cabanillas J Antibiotics (Basel). 2022; 11(12).

PMID: 36551433 PMC: 9774161. DOI: 10.3390/antibiotics11121776.


Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales.

Bouiller K, Zayet S, Lalloz P, Potron A, Gendrin V, Chirouze C Antibiotics (Basel). 2022; 11(2).

PMID: 35203801 PMC: 8868337. DOI: 10.3390/antibiotics11020198.


Novel Chromosomal Mutations Responsible for Fosfomycin Resistance in .

Cattoir V, Pourbaix A, Magnan M, Chau F, de Lastours V, Felden B Front Microbiol. 2020; 11:575031.

PMID: 33193186 PMC: 7607045. DOI: 10.3389/fmicb.2020.575031.


The Role of in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical Isolates.

Elliott Z, Barry K, Cox H, Stoesser N, Carroll J, Vegesana K J Clin Microbiol. 2019; 57(10).

PMID: 31340992 PMC: 6760957. DOI: 10.1128/JCM.00634-19.